• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » New chapters in the stent war annals

New chapters in the stent war annals

August 26, 2009 By MassDevice staff

Dr. Bruce Saffran, fresh from a $500 million court victory and a private settlement with Boston Scientific over a drug-eluting stent patent, is suing Abbott Laboratories (PDF) for violating the same patent with its Xience V stent.

Saffran, a New Jersey radiologist, won the half-billion-dollar verdict against the Natick, Mass.-based devices giant and later settled for an undisclosed amount (although BoSci later posted a $50 million charge on the deal).

Now, in a suit filed in U.S. District Court for Eastern Texas, Saffran is accusing Chicago-based Abbott of violating the same patent.

And Boston Scientific made news on another front in its patent war, after a Delaware judge threw out its lawsuit against Wall Cardiovascular Technologies and its half-owner, Cardio Holdings LLC.

Judge Susan Robinson dismissed the Delaware case, writing that her court lacks jurisdiction over the matter, which is also the subject of earlier lawsuits in Texas.

In 2007, Wall Cardiovascular sued Boston Scientific, Johnson & Johnson (and added Medtronic into the mix in 2008) for infringing a patent invented by W. Henry Wall. Wall Cardiovascular also sued Abbott over the same patent in 2008.

In response, BoSci moved to have the court rule for non-infringement, invalidity and unenforceability of the patent — and filed a suit on the same grounds in the Delaware court.

But Robinson, finding that the links to Delaware are tenuous and that the same issues are being argued in the Texas case filed by Boston Scientific, granted Wall Cardiovascular’s motion to dismiss.

Robinson is no stranger to the stent wars. Earlier this month, she apologized to both parties and the federal bench in overturning a prior, erroneous ruling that a pair of Johnson & Johnson unit Cordis Corp.’s stent patents were unenforceable.

Her 2002 decision in Cordis Corp. v. Boston Scientific Corp. et al. was wrong, she wrote in her reversal of the opinion, setting the stage for yet another round in the more than 10-year-old case.

“I note in this regard, with deep regret, that this matter ended up buried among the multitude of matters (and the tens of thousands of pages of motions, briefs and appendices) filed by the parties associated with just the various stent cases on my docket, not to mention the papers filed in the dozens of other patent cases on my docket. My sincere apologies to the Federal Circuit and to the parties,” Robinson wrote.

Filed Under: Business/Financial News, Drug-Eluting Stents

More recent news

  • Real-world data backs Route 92 reperfusion system
  • LivsMed unveils new surgical robot with telesurgery capabilities
  • JenaValve enrolls first patient in TAVR for AR study
  • HistoSonics expands insurance coverage for histotripsy treatment
  • Johnson & Johnson MedTech gets updated FDA nod for Varipulse PFA

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy